1. “Pink Limited securities aren’t eligible for the 15-day extension” Whoda thought, OTC didn’t shred that filing it at first look!
2. There is no published “review” period. Ok, “GRACE PERIOD”? Feel better?
Adding here as a bonus…OTC can take up to 30+ days in rare cases for “reviews”… “Not as published policy, but in practice as seen with many securities over time.”. Maybe there’s a Super Duper Extended Grace Period too?
Now, if you don’t get what I wrote prior, maybe have Arthur explain it to you. And while you’re at it, maybe you can explain to him that ELECTROME is technically a start-up company with a polished CEO given $150M via 3 exits, and team that has a stellar track record academically, clinically, and governmentally (you did great for him clarifying about the “Phantom Limb Pain” confusion).
That you suggest ELECTROME as an investment possibility - Wow, we agree!…but am keeping the BIEL thingy too.
Oh, about the “pumper” labeling. It seems Art doesn’t like labeling. Surprised he hasn’t called it out.
Market Data 
Markets 
